Literature DB >> 11011829

Bipolar II disorder and comorbidity.

E Vieta1, F Colom, A Martínez-Arán, A Benabarre, M Reinares, C Gastó.   

Abstract

The validity and reliability of the diagnosis of bipolar II disorder has been questioned by means of comorbidity with nonaffective disorders, including substance abuse, personality disorders, and anxiety disorders. This study examined the comorbid diagnosis of a sample of bipolar II patients, comparing patients with comorbidity and those with "pure" bipolar II disorder. Forty Research Diagnostic Criteria (RDC) bipolar II patients were assessed by means of the Schedule for Affective Disorders and Schizophrenia, Lifetime Version (SADS-L) and Structured Clinical Interview for DSM-III-R axis I (SCID-II) for personality disorders. Patients fulfilling RDC criteria for any psychiatric disorder (except personality disorders) or DSM-IV criteria for any personality disorder were compared with patients without comorbidity. For practical reasons, cyclothymia was not considered as a comorbid diagnosis. Half of the sample had lifetime comorbidity with other psychiatric disorders, mainly personality disorders (33%), substance abuse or dependence (21%), and anxiety disorders (8%). However, only the rates of suicidal ideation (74% v 24%, chi square [chi2] = 9.03, P = .003) and suicide attempts (45% v 5%, chi2 = 8.53, P = .003) were significantly different between patients with and without comorbidity. In summary, although the rates of comorbidity are relatively high in bipolar II disorder, most clinical and course variables are strikingly similar in patients with and without comorbidity except for suicidal behavior, suggesting that comorbidity does not reduce the validity of the diagnosis of bipolar II disorder.

Entities:  

Mesh:

Year:  2000        PMID: 11011829     DOI: 10.1053/comp.2000.9011

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  20 in total

1.  Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Analucía A Alegría; Deborah S Hasin; Edward V Nunes; Shang-Min Liu; Carrie Davies; Bridget F Grant; Carlos Blanco
Journal:  J Clin Psychiatry       Date:  2010-09       Impact factor: 4.384

2.  Borderline personality disorder and the bipolar disorder spectrum.

Authors:  Ronald Pies; Dean Mackinnon
Journal:  Psychiatry (Edgmont)       Date:  2007-03

3.  Considering Eligibility for Studies of Deep Brain Stimulation for Treatment-Resistant Depression: Insights From a Clinical Trial in Unipolar and Bipolar Depression.

Authors:  Megan M Filkowski; Helen S Mayberg; Paul E Holtzheimer
Journal:  J ECT       Date:  2016-06       Impact factor: 3.635

4.  A randomized pilot study of psychotherapy and quetiapine for the acute treatment of bipolar II depression.

Authors:  Holly A Swartz; Ellen Frank; Yu Cheng
Journal:  Bipolar Disord       Date:  2012-03       Impact factor: 6.744

5.  Threat sensitivity in bipolar disorder.

Authors:  Luma Muhtadie; Sheri L Johnson
Journal:  J Abnorm Psychol       Date:  2015-02

6.  DSM-IV depressive symptom expression among individuals with a history of hypomania: a comparison to those with or without a history of mania.

Authors:  Lauren M Weinstock; David Strong; Lisa A Uebelacker; Ivan W Miller
Journal:  J Psychiatr Res       Date:  2010-04-15       Impact factor: 4.791

7.  Commonalities and differences in characteristics of persons at risk for narcissism and mania.

Authors:  Daniel Fulford; Sheri L Johnson; Charles S Carver
Journal:  J Res Pers       Date:  2008-12

Review 8.  Problematic boundaries in the diagnosis of bipolar disorder: the interface with borderline personality disorder.

Authors:  Mark Zimmerman; Theresa A Morgan
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

9.  Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies.

Authors:  R Bruce Lydiard; Larry Culpepper; Helena Schiöler; Urban Gustafsson; Björn Paulsson
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 10.  Differential Diagnosis of Bipolar II Disorder and Borderline Personality Disorder.

Authors:  Adam Bayes; Gordon Parker; Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2019-11-20       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.